Ultima Hexarelin — Research Summary
Hexarelin is a synthetic growth hormone-releasing peptide (GHRP) that functions as a potent ghrelin receptor agonist in laboratory research environments. This hexapeptide compound demonstrates significant affinity for growth hormone secretagogue receptors (GHS-R) and has been extensively investigated in preclinical models for its capacity to stimulate pulsatile growth hormone release through distinct molecular pathways. Researchers examining growth hormone axis modulation frequently utilise hexarelin as a reference compound due to its well-characterised pharmacological profile and reproducible effects in controlled laboratory settings. The peptide’s unique structure, incorporating D-tryptophan and D-phenylalanine residues, contributes to its enhanced stability and receptor selectivity compared to naturally occurring growth hormone releasing factors. Stroid UK Shop have employed hexarelin in studies investigating neuroendocrine function, metabolic regulation, and cellular signalling cascades.
Laboratory Applications
In cellular biology research, hexarelin serves as an invaluable tool for investigating growth hormone secretagogue receptor function and downstream signalling pathways. The compound has been utilised in studies examining calcium mobilisation, cyclic adenosine monophosphate (cAMP) accumulation, and protein kinase activation within pituitary cell cultures. Metabolic research applications include investigations into glucose homeostasis, lipid metabolism, and insulin sensitivity using various in-vitro model systems. Researchers studying hexarelin peptide mechanisms have documented its effects on cardiac muscle cells, hepatocytes, and adipose tissue cultures. The compound’s ability to cross the blood-brain barrier in animal models has made it particularly valuable for neuroscience research examining hypothalamic-pituitary axis function. Additionally, hexarelin demonstrates cardioprotective properties in isolated heart preparations, leading to its investigation in cardiovascular research protocols examining ischemia-reperfusion injury models.
Technical Specifications
| Parameter | Value |
|---|---|
| Molecular Weight | 887.04 g/mol |
| Sequence | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| CAS Number | 140703-51-1 |
| Purity | ≥98% (HPLC verified) |
| Storage Temperature | -20°C (lyophilised powder) |
| Reconstitution | Bacteriostatic water or PBS |
| Stability | 36 months when stored properly |
This Ultima Pharmaceuticals formulation provides researchers with pharmaceutical-grade hexarelin suitable for demanding experimental protocols. The lyophilised powder format ensures optimal stability during storage and transport while maintaining consistent potency across experimental batches. Quality control testing includes high-performance liquid chromatography (HPLC) analysis, mass spectrometry verification, and endotoxin testing to meet stringent research standards. Researchers investigating selective androgen receptor modulators often utilise hexarelin as a control compound in studies examining growth factor interactions. The compound’s water solubility and neutral pH characteristics make it compatible with most standard laboratory buffers and cell culture media systems.
Research Compliance
This hexarelin product is manufactured exclusively for in-vitro research applications and is not intended for human consumption, therapeutic use, or any form of clinical application. Researchers must ensure proper laboratory protocols are followed when handling this peptide compound, including appropriate personal protective equipment and containment procedures. All experimental work should be conducted within properly equipped research facilities by qualified personnel familiar with peptide handling procedures. The compound should be stored according to manufacturer specifications and used only for legitimate scientific research purposes. Peptide research compounds require careful documentation of experimental protocols and adherence to institutional biosafety guidelines. This product is intended solely for qualified researchers conducting approved studies in accredited research institutions and is not suitable for any other applications.
